Cited by

• Hemodynamic variation is a dominant contributing factor of Graves' hyperthyroidism complication: Heart failure and fatal liver dysfunction, a case report and analysis.

  Li Z, Wang J, Zeng J, Xue J, Li X, Su J, Fang Y. Li Z, et al. Clin Case Rep. 2022 Feb 3;10(2):e05289. doi: 10.1002/ccr3.5289. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35140941 Free PMC article.
• Is There Any Relationship between TSH Levels and Prognosis in Acute Coronary Syndrome?

  Soeiro AM, Araújo VA, Vella JP, Bossa AS, Biselli B, Leal TCAT, Soeiro MCFA, Serrano CV Jr, Mueller C, Oliveira Junior MT. Soeiro AM, et al. Arq Bras Cardiol. 2018 Feb;110(2):113-118. doi: 10.5935/abc.20180019. Arq Bras Cardiol. 2018. PMID: 29561989 Free PMC article.
• Thyrotoxic Cardiomyopathy: State of the Art.

  Quiroz-Aldave JE, Durand-Vásquez MDC, Lobato-Jeri CJ, Muñoz-Moreno JM, Deutz Gómez Condori DC, Ildefonso-Najarro SP, Contreras-Yametti F, Zavaleta-Gutiérrez F, Concepción-Urteaga L, Concepción-Zavaleta MJ. Quiroz-Aldave JE, et al. touchREV Endocrinol. 2023 May;19(1):78-84. doi: 10.17925/EE.2023.19.1.78. Epub 2023 Feb 7. touchREV Endocrinol. 2023. PMID: 37313242 Free PMC article. Review.
• Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

  De Ciuceis C, Pilu A, Cappelli C, Porteri E, Zani F, Santoro A, Gandossi E, Boari GE, Rizzardi N, Castellano M, Rizzoni D, Agabiti Rosei E. De Ciuceis C, et al. J Endocrinol Invest. 2011 May;34(5):335-9. doi: 10.1007/BF03347455. Epub 2010 Jun 28. J Endocrinol Invest. 2011. PMID: 20585201
• Endocrine system dysfunction and chronic heart failure: a clinical perspective.

  Lisco G, Giagulli VA, Iovino M, Zupo R, Guastamacchia E, De Pergola G, Iacoviello M, Triggiani V. Lisco G, et al. Endocrine. 2022 Feb;75(2):360-376. doi: 10.1007/s12020-021-02912-w. Epub 2021 Oct 28. Endocrine. 2022. PMID: 34713389 Free PMC article.